Intelligence Unit
Special Reports
Special Events
Subscribe
Sponsored
Departments
- Leadership
- Finance
- Technology
- Physicians
- Community Hospitals
- Health Plans
- Marketing
- Quality
- Nursing
- HR
Follow Us
Cost-effectiveness of cancer drugs is questioned
Wall Street Journal, June 30, 2009
The widespread use of expensive cancer drugs to prolong patients’ lives by just weeks or months was called into question by an article published in the Journal of the National Cancer Institute. But while some policy experts consider the rationing of healthcare resources inevitable in the quest to control medical spending, many Americans have long resisted putting the collective fiscal good over their individual health.
Most Viewed
Most Emailed
- Primary Care Docs Average More Hospital Revenue Than Specialists
- 69% of Employers Plan to Offer Healthcare Coverage After 2014
- Building a Better Healthcare Board
- How Chargemaster Data May Affect Hospital Revenue
- Q&A: Catholic Health Initiatives' New Senior VP for Capital Finance
- Hospital Pricing Irks Nurses; More Jobs, Less Pay
- CMS Seeks to 'Rapidly Reduce' Medicare Spending with $1B in Grants
- ED Physicians Key to Half of Hospital Admissions
- Quiet ORs Better for Patient Safety
- CMS Releases Hospital Pricing Data
